Researchers reveal why people with allergic asthma are protected from severe COVID

The vast majority of people infected with the omicron variant of SARS-CoV-2 experience mild cold-like symptoms, moderate flu-like symptoms, or no symptoms at all, but the virus is so transmissible that it still spread deep into lung tissue to cause severe disease and death in thousands of people in the United States in 2022 alone.

Related Keywords

United States ,Caitlin Edwards ,Camille Ehre ,Cameron Morrison ,Emily Henderson ,Gillings School Of Global Public Health ,School Of Medicine ,Marsico Lung Institute ,Children Research Institute ,Department Of Microbiology ,Proceedings Of The National Academy Sciences ,University Of North Carolina At Chapel Hill ,North Carolina ,Chapel Hill ,National Academy ,Ralph Baric ,Kenan Distinguished Professor ,Global Public Health ,Ace2 ,Asthma ,Fell ,Hronic ,Chronic Obstructive Pulmonary Disease ,Gold ,Ytokine ,Emphysema ,Flu ,Nterleukin ,Medicine ,Micron ,Protein ,Research ,Cars ,Ars Cov 2 ,Virus ,